Cargando…
Endocannabinoids and Precision Medicine for Mood Disorders and Suicide
Autor principal: | Pinna, Graziano |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8173054/ https://www.ncbi.nlm.nih.gov/pubmed/34093274 http://dx.doi.org/10.3389/fpsyt.2021.658433 |
Ejemplares similares
-
Bright Light as a Personalized Precision Treatment of Mood Disorders
por: Maruani, Julia, et al.
Publicado: (2019) -
Editorial: Impact of the Coronavirus Pandemic (COVID-19) on Mood Disorders and Suicide
por: Ciacchella, Chiara, et al.
Publicado: (2022) -
Suicides in Mood Disorders in Psychiatric Settings in Nordic National Register–Based Studies
por: Isometsä, Erkki T.
Publicado: (2020) -
Do Suicide Attempts of Mood Disorder Patients Directly Increase the Risk for a Reattempt?
por: Aaltonen, Kari I., et al.
Publicado: (2020) -
Development and validation of a nomogram to predict suicidal behavior in female patients with mood disorder
por: Liang, Sixiang, et al.
Publicado: (2023)